Shervin Assassi is a Rheumatology/Immunology physician affiliated with University of Houston. OpenAlex indexes 356 publications with 12,776 citations (h-index 66); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6431 Fannin St
Msb 5.270
Houston, TX 770301501
Telephone
713-500-6900Provider last certified this registry record 24 Jun 2025.
Clinical trials
- Optical Elastography of Systemic Sclerosis Skin
Sponsor: The University of Texas Health Science Center, Houston
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim International GmbHProgram year202535 payments$73,247openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202510 payments$16,988openpaymentsdata.cms.gov ↗
- CSL BehringProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
7 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Hypoxia-Driven NUDT21-Mediated APA Promotes Lung and Skin Fibrosis in Systemic Sclerosis
University of Texas Hlth Sci Ctr Houston
FY2026$623,286R01AR087804 - Interferon Regulatory Factor 7 Links Interferon Pathway Activation to the Exaggerates Fibrotic Response in Systemic Sclerosis
University of Texas Hlth Sci Ctr Houston
FY2026$278,973R01AR081280 - Interferon Regulatory Factor 7 Links Interferon Pathway Activation to the Exaggerates Fibrotic Response in Systemic Sclerosis
University of Texas Hlth Sci Ctr Houston
FY2025$319,352R01AR081280
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Arthur Garson, MD
University of Houston
Ertug Kovanci, MD
University of Houston
Elizabeth Newlin, MD
University of Houston
Benjamin Aertker, MD
University of Houston
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”